Hybrid nanocrystals: University of Kentucky US20060280680A1.

Expert Opinion on Therapeutic Patents
Jamie E RayahinRichard A Gemeinhart

Abstract

This patent application claims an interesting and novel combination of passive accumulation of drug nanocrystals within diseased tissue, in combination with active uptake of the nanocrystals by diseased cells. The patent application further claims the hybrid nanocrystals combining imaging or stabilizing molecules as inclusions in the crystal matrix. There is a focus on cancer chemotherapy and imaging, but the initial claims are not disease specific. In this patent evaluation, the novelty and utility of this application is examined, while the state of the art in nanocrystal formulations and formulation is discussed.

References

Jul 1, 1979·Arthritis and Rheumatism·P A Simkin
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D C HooperS V Spitsin
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Feb 13, 2001·Drug Discovery Today·A Hinde
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·R K Jain
Oct 24, 2001·Advanced Drug Delivery Reviews·H KimuraY Ogura
Nov 17, 2001·Chemical Reviews·B Kahr, R W Gurney
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
May 17, 2003·Nature Reviews. Drug Discovery·Ruth Duncan
May 12, 2004·Current Drug Targets·T MinkoY Wang
Sep 2, 2004·Nature Reviews. Drug Discovery·Barrett E Rabinow
Dec 29, 2004·Langmuir : the ACS Journal of Surfaces and Colloids·Alisar S ZahrMichael V Pishko
Sep 1, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Cornelia M Keck, Rainer H Müller
Aug 11, 2006·Nature Reviews. Cancer·Ruth Duncan
Jan 4, 2007·Journal of the American Chemical Society·Dejan-Kresimir Bu Ccaron Ar, Leonard R Macgillivray
May 5, 2007·Molecular Pharmaceutics·Andrew V Trask
Jul 3, 2007·Advanced Drug Delivery Reviews·Filippos KesisoglouYunhui Wu
Aug 11, 2007·Journal of Pharmaceutical Sciences·Harikrishna DevalapallyMansoor M Amiji
Mar 14, 2008·Toxicologic Pathology·Elaine M Merisko-Liversidge, Gary G Liversidge
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Jul 26, 2008·Nature Nanotechnology·Wendy R SanhaiMauro Ferrari
Aug 8, 2008·Nature Nanotechnology·Haifei ZhangSteven P Rannard
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Jun 9, 2009·Crystal Growth & Design·Nate Schultheiss, Ann Newman
Nov 12, 2009·Nature Reviews. Molecular Cell Biology·Patrick T CaswellJim C Norman
Aug 3, 2010·International Journal of Pharmaceutics·Ranjita Shegokar, Rainer H Müller
Sep 15, 2010·Nature Reviews. Clinical Oncology·Rakesh K Jain, Triantafyllos Stylianopoulos
Jan 27, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rainer H MüllerCornelia M Keck
Jun 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·You Han Bae, Kinam Park
Jun 18, 2011·International Journal of Pharmaceutics·Hua ZhangTonglei Li
Jul 15, 2011·Traffic·Anna Hupalowska, Marta Miaczynska
Oct 6, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H Müller, C M Keck
Dec 24, 2011·Nature Cell Biology·Mihaela Anitei, Bernard Hoflack

❮ Previous
Next ❯

Citations

Aug 22, 2015·Nanomedicine·Yi LuTonglei Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.